Basilea Pharmaceutica AG announced a partnership with INCATE to support the development of antibacterial and antifungal therapies. Basilea will bring its expertise to help identify and promote innovative early-stage innovations in the field. The partnership aims to bridge the gap between academic research and life-saving medications. INCATE is a non-profit partnership that brings together research, industry, entrepreneurs, and investors to fill and strengthen the pipeline with new antibiotics, antifungals, and technology platforms. Basilea is a biopharmaceutical company focused on discovering, developing, and marketing innovative medications to help patients with severe bacterial or fungal infections.

Read more at GlobeNewswire: Basilea geht Partnerschaft mit INCATE ein, um Innovationen